Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer

T cells recognize cancer cells via human leukocyte antigen (HLA)/peptide complexes and, when disease overtakes these immune mechanisms, immunotherapy can exogenously target these same HLA/peptide surface markers. We previously identified an HLA-A2-presented peptide derived from macrophage migration...

全面介紹

Na minha lista:
書目詳細資料
發表在:Mol Cancer Ther
Main Authors: Patterson, Andrea M, Kaabinejadian, Saghar, McMurtrey, Curtis P, Bardet, Wilfried, Jackson, Ken W, Zuna, Rosemary E, Husain, Sanam, Adams, Gregory P, MacDonald, Glen, Dillon, Rachelle L., Ames, Harold, Buchli, Rico, Hawkins, Oriana E, Weidanz, Jon A, Hildebrand, William H
格式: Artigo
語言:Inglês
出版: 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747837/
https://ncbi.nlm.nih.gov/pubmed/26719579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0658
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍